• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于集成学习的非小细胞肺癌中表皮生长因子受体突变状态的预测

Prediction of EGFR Mutation Status in Non-Small Cell Lung Cancer Based on Ensemble Learning.

作者信息

Feng Youdan, Song Fan, Zhang Peng, Fan Guangda, Zhang Tianyi, Zhao Xiangyu, Ma Chenbin, Sun Yangyang, Song Xiao, Pu Huangsheng, Liu Fei, Zhang Guanglei

机构信息

Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China.

School of Medical Imaging, Shanxi Medical University, Taiyuan, China.

出版信息

Front Pharmacol. 2022 Jun 27;13:897597. doi: 10.3389/fphar.2022.897597. eCollection 2022.

DOI:10.3389/fphar.2022.897597
PMID:35833032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9271946/
Abstract

We aimed to identify whether ensemble learning can improve the performance of the epidermal growth factor receptor (EGFR) mutation status predicting model. We retrospectively collected 168 patients with non-small cell lung cancer (NSCLC), who underwent both computed tomography (CT) examination and EGFR test. Using the radiomics features extracted from the CT images, an ensemble model was established with four individual classifiers: logistic regression (LR), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost). The synthetic minority oversampling technique (SMOTE) was also used to decrease the influence of data imbalance. The performances of the predicting model were evaluated using the area under the curve (AUC). Based on the 26 radiomics features after feature selection, the SVM performed best (AUCs of 0.8634 and 0.7885 on the training and test sets, respectively) among four individual classifiers. The ensemble model of RF, XGBoost, and LR achieved the best performance (AUCs of 0.8465 and 0.8654 on the training and test sets, respectively). Ensemble learning can improve the model performance in predicting the EGFR mutation status of patients with NSCLC, showing potential value in clinical practice.

摘要

我们旨在确定集成学习是否能够提高表皮生长因子受体(EGFR)突变状态预测模型的性能。我们回顾性收集了168例非小细胞肺癌(NSCLC)患者,这些患者均接受了计算机断层扫描(CT)检查和EGFR检测。利用从CT图像中提取的放射组学特征,建立了一个包含四个独立分类器的集成模型:逻辑回归(LR)、支持向量机(SVM)、随机森林(RF)和极端梯度提升(XGBoost)。还使用了合成少数过采样技术(SMOTE)来减少数据不平衡的影响。使用曲线下面积(AUC)评估预测模型的性能。基于特征选择后的26个放射组学特征,在四个独立分类器中,SVM表现最佳(训练集和测试集的AUC分别为0.8634和0.7885)。RF、XGBoost和LR的集成模型取得了最佳性能(训练集和测试集的AUC分别为0.8465和0.8654)。集成学习可以提高预测NSCLC患者EGFR突变状态的模型性能,在临床实践中显示出潜在价值。

相似文献

1
Prediction of EGFR Mutation Status in Non-Small Cell Lung Cancer Based on Ensemble Learning.基于集成学习的非小细胞肺癌中表皮生长因子受体突变状态的预测
Front Pharmacol. 2022 Jun 27;13:897597. doi: 10.3389/fphar.2022.897597. eCollection 2022.
2
Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.使用多模态成像和机器学习算法的下一代放射基因组学测序预测非小细胞肺癌患者的EGFR和KRAS突变状态
Mol Imaging Biol. 2020 Aug;22(4):1132-1148. doi: 10.1007/s11307-020-01487-8.
3
PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.PET/CT影像组学特征:非小细胞肺癌患者接受酪氨酸激酶抑制剂治疗时表皮生长因子受体突变状态及生存结果预测的潜在生物标志物
Front Oncol. 2022 Jun 21;12:894323. doi: 10.3389/fonc.2022.894323. eCollection 2022.
4
Development and Validation of Machine Learning Models to Predict Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Multi-Center Retrospective Radiomics Study.开发和验证机器学习模型预测非小细胞肺癌表皮生长因子受体突变:一项多中心回顾性放射组学研究。
Cancer Control. 2022 Jan-Dec;29:10732748221092926. doi: 10.1177/10732748221092926.
5
Radiomics feature analysis and model research for predicting histopathological subtypes of non-small cell lung cancer on CT images: A multi-dataset study.基于 CT 图像的非小细胞肺癌组织病理亚型预测的影像组学特征分析及模型研究:多数据集研究
Med Phys. 2023 Jul;50(7):4351-4365. doi: 10.1002/mp.16233. Epub 2023 Feb 1.
6
Predicting the T790M mutation in non-small cell lung cancer (NSCLC) using brain metastasis MR radiomics: a study with an imbalanced dataset.利用脑转移磁共振影像组学预测非小细胞肺癌(NSCLC)中的T790M突变:一项针对不均衡数据集的研究
Discov Oncol. 2024 Sep 14;15(1):447. doi: 10.1007/s12672-024-01333-1.
7
The predictive value of [F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma.[F]FDG PET/CT影像组学联合临床特征对不同临床分期肺腺癌EGFR突变状态的预测价值
EJNMMI Res. 2023 Apr 4;13(1):26. doi: 10.1186/s13550-023-00977-4.
8
Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer.用于预测肺癌中表皮生长因子受体(EGFR)突变的可解释机器学习模型
Front Oncol. 2022 Jun 23;12:924144. doi: 10.3389/fonc.2022.924144. eCollection 2022.
9
Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.特征归一化对放射基因组学分析的影响:从非小细胞肺癌PET/CT图像预测EGFR和KRAS突变
Comput Biol Med. 2022 Mar;142:105230. doi: 10.1016/j.compbiomed.2022.105230. Epub 2022 Jan 11.
10
Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on F FDG-PET/CT.基于 F-FDG-PET/CT 预测非小细胞肺癌组织学分型和表皮生长因子受体突变状态的梯度提升树模型的效用。
Ann Nucl Med. 2020 Jan;34(1):49-57. doi: 10.1007/s12149-019-01414-0. Epub 2019 Oct 28.

引用本文的文献

1
Radiomics based on dual-layer spectral detector CT for predicting EGFR mutation status in non-small cell lung cancer.基于双层光谱探测器CT的影像组学用于预测非小细胞肺癌中的表皮生长因子受体突变状态
J Appl Clin Med Phys. 2025 Feb;26(2):e14616. doi: 10.1002/acm2.14616. Epub 2024 Dec 14.
2
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
3
Radiogenomic analysis for predicting lymph node metastasis and molecular annotation of radiomic features in pancreatic cancer.

本文引用的文献

1
Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents.非小细胞肺癌:新兴的分子靶向和免疫治疗药物。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188636. doi: 10.1016/j.bbcan.2021.188636. Epub 2021 Oct 14.
2
Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.奥希替尼用于表皮生长因子受体(EGFR)突变型肺癌:现有及新出现临床数据综述
Onco Targets Ther. 2021 Aug 26;14:4579-4597. doi: 10.2147/OTT.S227032. eCollection 2021.
3
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
基于影像组学的胰腺癌淋巴结转移预测及影像组学特征的分子学标记物分析
J Transl Med. 2024 Jul 29;22(1):690. doi: 10.1186/s12967-024-05479-y.
4
Hallmarks of cancer resistance.癌症耐药性的特征。
iScience. 2024 May 15;27(6):109979. doi: 10.1016/j.isci.2024.109979. eCollection 2024 Jun 21.
5
EfficientNet-Based System for Detecting EGFR-Mutant Status and Predicting Prognosis of Tyrosine Kinase Inhibitors in Patients with NSCLC.基于 EfficientNet 的系统,用于检测 NSCLC 患者的 EGFR 突变状态和预测酪氨酸激酶抑制剂的预后。
J Imaging Inform Med. 2024 Jun;37(3):1086-1099. doi: 10.1007/s10278-024-01022-z. Epub 2024 Feb 15.
全球及中国癌症负担的变化趋势:对《2020年全球癌症统计数据》的二次分析
Chin Med J (Engl). 2021 Mar 17;134(7):783-791. doi: 10.1097/CM9.0000000000001474.
4
Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysis.酪氨酸激酶抑制剂在携带表皮生长因子受体突变的晚期非小细胞肺癌中的疗效和安全性:一项网状荟萃分析。
Lung Cancer Manag. 2020 Nov 23;10(1):LMT43. doi: 10.2217/lmt-2020-0011.
5
Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS.鉴定影像表型与肺癌相关突变状态(EGFR 和 KRAS)之间的关系。
Sci Rep. 2020 Feb 27;10(1):3625. doi: 10.1038/s41598-020-60202-3.
6
Assessing EGFR gene mutation status in non-small cell lung cancer with imaging features from PET/CT.利用PET/CT的影像特征评估非小细胞肺癌中的表皮生长因子受体(EGFR)基因突变状态。
Nucl Med Commun. 2019 Aug;40(8):842-849. doi: 10.1097/MNM.0000000000001043.
7
Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.利用放射组学特征和随机森林模型通过无创成像识别肺腺癌中的 EGFR 突变。
Eur Radiol. 2019 Sep;29(9):4742-4750. doi: 10.1007/s00330-019-06024-y. Epub 2019 Feb 18.
8
Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.采用双能量光谱 CT 检测肺腺癌中表皮生长因子受体突变。
Eur Radiol. 2019 Jun;29(6):2989-2997. doi: 10.1007/s00330-018-5756-9. Epub 2018 Oct 26.
9
A radiogenomic dataset of non-small cell lung cancer.非小细胞肺癌的放射基因组数据集。
Sci Data. 2018 Oct 16;5:180202. doi: 10.1038/sdata.2018.202.
10
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.